52 related articles for article (PubMed ID: 24825746)
1. Biology of breast cancer during pregnancy using genomic profiling.
Azim HA; Brohée S; Peccatori FA; Desmedt C; Loi S; Lambrechts D; Dell'Orto P; Majjaj S; Jose V; Rotmensz N; Ignatiadis M; Pruneri G; Piccart M; Viale G; Sotiriou C
Endocr Relat Cancer; 2014 Aug; 21(4):545-54. PubMed ID: 24825746
[TBL] [Abstract][Full Text] [Related]
2. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.
Azim HA; Peccatori FA; Brohée S; Branstetter D; Loi S; Viale G; Piccart M; Dougall WC; Pruneri G; Sotiriou C
Breast Cancer Res; 2015 Feb; 17():24. PubMed ID: 25849336
[TBL] [Abstract][Full Text] [Related]
3. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives.
Ades F; Zardavas D; Bozovic-Spasojevic I; Pugliano L; Fumagalli D; de Azambuja E; Viale G; Sotiriou C; Piccart M
J Clin Oncol; 2014 Sep; 32(25):2794-803. PubMed ID: 25049332
[TBL] [Abstract][Full Text] [Related]
4. Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?
Sonnenblick A; Fumagalli D; Sotiriou C; Piccart M
Cancer Treat Rev; 2014 Oct; 40(9):1089-95. PubMed ID: 25151406
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature.
Raphael J; Trudeau ME; Chan K
Curr Oncol; 2015 Mar; 22(Suppl 1):S8-S18. PubMed ID: 25848342
[TBL] [Abstract][Full Text] [Related]
6. Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.
Azim HA; Vingiani A; Peccatori F; Viale G; Loi S; Pruneri G
Breast; 2015 Jun; 24(3):290-3. PubMed ID: 25702955
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?
Pagani O; Ruggeri M; Manunta S; Saunders C; Peccatori F; Cardoso F; Kaufman B; Paluch-Shimon S; Gewefel H; Gallerani E; Abulkhair OM; Pistilli B; Warner E; Saloustros E; Perey L; Zaman K; Rabaglio M; Gelber S; Gelber RD; Goldhirsch A; Korde L; Azim HA; Partridge AH
Breast; 2015 Jun; 24(3):201-7. PubMed ID: 25662412
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy associated breast cancer: an institutional experience.
Gogia A; Deo SV; Shukla NK; Mohanti BK; Raina V
Indian J Cancer; 2014; 51(2):167-9. PubMed ID: 25104202
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer during pregnancy-The oncologist's point of view.
Matikas A; Bergh J
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):775-778. PubMed ID: 37983830
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features, treatment, and prognosis of pregnancy-associated breast cancer.
Li Y; Wang Y; Sun Q; Shen S
Front Oncol; 2022; 12():978671. PubMed ID: 36591448
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles.
Sajjadi E; Venetis K; Noale M; Azim HA; Blundo C; Bonizzi G; Di Loreto E; Scarfone G; Ferrero S; Maggi S; Barberis M; Veronesi P; Galimberti VE; Viale G; Fusco N; Peccatori FA; Guerini-Rocco E
Cells; 2022 Jul; 11(15):. PubMed ID: 35892583
[TBL] [Abstract][Full Text] [Related]
12. The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis.
Andrikopoulou A; Chatzinikolaou S; Kyriopoulos I; Bletsa G; Kaparelou M; Liontos M; Dimopoulos MA; Zagouri F
Front Oncol; 2021; 11():797505. PubMed ID: 35127508
[TBL] [Abstract][Full Text] [Related]
13. Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer.
Li H; Prever L; Hirsch E; Gulluni F
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298731
[TBL] [Abstract][Full Text] [Related]
14. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives.
Chang DY; Ma WL; Lu YS
Ther Clin Risk Manag; 2021; 17():193-207. PubMed ID: 33707948
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer During Pregnancy: A Marked Propensity to Triple-Negative Phenotype.
Allouch S; Gupta I; Malik S; Al Farsi HF; Vranic S; Al Moustafa AE
Front Oncol; 2020; 10():580345. PubMed ID: 33425733
[TBL] [Abstract][Full Text] [Related]
16. The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review.
Korakiti AM; Moutafi M; Zografos E; Dimopoulos MA; Zagouri F
Front Oncol; 2020; 10():1773. PubMed ID: 33014874
[TBL] [Abstract][Full Text] [Related]
17. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.
Wang B; Yu J; Sun Z; Luh F; Lin D; Shen Y; Wang T; Zhang Q; Liu X
Mol Carcinog; 2020 Aug; 59(8):908-922. PubMed ID: 32346924
[TBL] [Abstract][Full Text] [Related]
18. Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets.
Zhang J; Zhou YJ; Yu ZH; Chen AX; Yu Y; Wang X; Cao XC
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171715
[TBL] [Abstract][Full Text] [Related]
19. Human Mitotic Centromere-Associated Kinesin Is Targeted by MicroRNA 485-5p/181c and Prognosticates Poor Survivability of Breast Cancer.
Lu H; Wang C; Xue L; Zhang Q; Luh F; Wang J; Lin TG; Yen Y; Liu X
J Oncol; 2019; 2019():2316237. PubMed ID: 31073307
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database.
Bae SY; Kim KS; Kim JS; Lee SB; Park BW; Lee SW; Lee HJ; Kim HK; You JY; Jung SP;
J Breast Cancer; 2018 Dec; 21(4):425-432. PubMed ID: 30607164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
